About This NIH Stroke Scale Calculator
This NIH Stroke Scale (NIHSS) Calculator is a comprehensive digital tool designed for healthcare professionals to systematically assess the severity of an acute stroke. The NIHSS is a standardized 11-item examination that provides a quantitative measure of stroke-related neurologic deficits. This calculator streamlines the scoring process, allowing for rapid and reliable calculation at the bedside. The resulting score is critical for clinical decision-making, particularly regarding the administration of intravenous thrombolytics (tenecteplase or alteplase), and serves as a robust tool for tracking clinical changes over time.
Detailed Examination Guidelines
For accurate scoring, each item should be assessed according to the standardized NIHSS administration protocol.
1. Level of Consciousness (a, b, c)
1a: Assessed by observing the patient. Arouse the patient if necessary, first with voice, then by shaking, and finally with a painful stimulus if unresponsive. 1b: Ask the patient the current month and their age. Do not provide clues. Aphasic or stuporous patients who do not comprehend the questions score 2. 1c: Ask the patient to open and close their eyes, and then to grip and release their non-paretic hand. Only the first attempt is scored.
2. Best Gaze
Test only horizontal eye movements. Ask the patient to follow your finger or face. Score partial gaze palsy if movement is abnormal in one or both eyes. Score forced deviation if there is a tonic deviation that cannot be overcome.
3. Visual Fields
Test the four visual quadrants by confrontation (e.g., finger counting or wiggling). If the patient is blind, this must be documented and a score of 3 is given.
4. Facial Palsy
Ask the patient to show their teeth, raise their eyebrows, and squeeze their eyes shut. Score based on the symmetry of facial movement, especially in the lower face.
5 & 6. Motor Arm and Leg
Test each limb one at a time. For the arm, position the limb at 90 degrees (if sitting) or 45 degrees (if supine) and hold for 10 seconds. For the leg, position at 30 degrees (supine) for 5 seconds. Score based on any downward drift. Do not test a limb that is immobilized or has had a joint replacement (score as UN – Untestable).
7. Limb Ataxia
Test for cerebellar function with the finger-nose-finger and heel-to-shin tests on both sides. This is scored only if ataxia is present out of proportion to any weakness.
8. Sensory
Use a pin to test for sensation or grimace to stimulus on the face, arms (forearms), and legs (shins). A score of 1 indicates mild-to-moderate sensory loss; 2 indicates a dense loss of sensation.
9. Best Language (Aphasia)
Assess the patient’s ability to describe what is happening in the provided picture scene, name the items on the naming sheet, and read the provided sentences. This item evaluates for aphasia.
10. Dysarthria
Assess speech clarity by having the patient repeat the provided list of words. Slurring or unclear articulation is scored. If the patient is intubated or cannot speak for other reasons, score as UN.
11. Extinction and Inattention (Neglect)
This is scored only if present. Test by touching the patient on both sides simultaneously while their eyes are closed and asking where they feel the touch. Also test by showing fingers in both visual fields simultaneously.
Clinical Interpretation & Limitations
The total NIHSS score ranges from 0 to 42, with higher scores indicating greater stroke severity. The score is commonly interpreted as follows:
- 0: No stroke symptoms
- 1-4: Minor stroke
- 5-15: Moderate stroke
- 16-20: Moderate-to-severe stroke
- 21-42: Severe stroke
This score is a powerful predictor of short- and long-term outcomes after stroke. A change of 2 to 4 points is often considered clinically significant.
Limitations
While the NIHSS is the gold standard, it has limitations. It is weighted towards anterior circulation strokes and may underestimate the severity of certain posterior circulation strokes. Factors such as intubation, language barriers, or pre-existing neurologic deficits can make some items difficult to assess accurately. This calculator should be used by trained professionals as part of a comprehensive neurologic evaluation.
Frequently Asked Questions (FAQ)
1. Why is NIHSS certification important?
Certification ensures that all providers are administering and scoring the scale in the exact same standardized manner. This inter-rater reliability is crucial for making accurate treatment decisions (like giving tPA) and for the validity of clinical research.
2. How is the NIHSS performed on an intubated patient?
Certain items become “untestable.” For item 10 (Dysarthria), the patient is intubated and cannot speak, so it is scored as Untestable (UN), which contributes 0 points. For item 9 (Language), the examiner uses non-verbal cues and the picture description task to assess for aphasia as best as possible.
3. Does a score of 0 guarantee there was no stroke?
No. A score of 0 means there are no measurable neurologic deficits on the scale. A patient could still have had a stroke with subtle symptoms not captured by the NIHSS, or a stroke in a location like the cerebellum or brainstem that causes significant disability (e.g., vertigo, ataxia) but results in a low score.
4. What’s the difference between dysarthria and aphasia on the scale?
Aphasia (Item 9) refers to a language problem—difficulty understanding, generating, or retrieving words. Dysarthria (Item 10) is a motor speech problem—difficulty articulating words clearly due to muscle weakness or incoordination (slurred speech).
5. Can this scale be used for hemorrhagic strokes?
Yes. The NIHSS measures the neurologic deficit regardless of the stroke type (ischemic or hemorrhagic). Its primary use is for guiding ischemic stroke treatment, but it is a valuable assessment tool for all acute stroke patients.
Related Calculators
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
